The New England Journal - Journal Watch: Year in Review 2016
And Finally … Rounding Out Our Top 10: Additional notable 2016 studies
Editor: Allan S. Brett
Cardiovascular Outcomes with Newer Antidiabetes Drugs
Editor: Paul S. Mueller
Does CPAP Prevent Adverse CV Events in Patients with Obstructive Sleep Apnea?
Editor: Kirsten E. Fleischmann
Focus on Inappropriate Opioid Use Intensifies
Editor: Thomas L. Schwenk
New Sepsis-3 Definitions Await Confirmatory Data
Editor: Patricia Kritek
Pulmonary Embolism as a Cause of Syncope
Editor: Allan S. Brett
Racial Differences Persist in End-of-Life Care
Editor: Bruce Soloway
Randomized Comparison of Surgery, Radiotherapy, and Surveillance for Prostate Cancer
Editor: Allan S. Brett
With Oxygen, Could Less Be More?
Editor: Patricia Kritek
Zika Makes Headlines
Editor: Abigail Zuger, MD

Liraglutide and Cardiovascular Outcomes in Patients with Long-Standing Type 2 Diabetes Voltar

Editor Associado: Allan S. Brett

Cardiovascular Outcomes with Newer Antidiabetes Drugs - Editor: Paul S. Mueller

Artigo Autor(es) Referência
Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope? Ingelfinger Julie R, Rosen Clifford J The New England journal of medicine. 2016 Jul; 375(Jul):380-2. doi: 10.1056/NEJMe1607413. pii: .
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. Marso Steven P, Daniels Gilbert H, Brown-Frandsen Kirstine, Kristensen Peter, Mann Johannes F E, Nauck Michael A, Nissen Steven E, Pocock Stuart, Poulter Neil R, Ravn Lasse S, Steinberg William M, Stockner Mette, Zinman Bernard, Bergenstal Richard M, Buse John B, , The New England journal of medicine. 2016 07; 375(07):311-22. doi: 10.1056/NEJMoa1603827. pii: .
Nenhuma revista foi definida para este congresso.